Pharmacological treatment of diabetic peripheral neuropathy.
Authors:
- Kenneth CohenKCKenneth Cohen
- Nataliya ShinkazhNSNataliya Shinkazh
- Jerry FrankJFJerry Frank
- Igor IsraelIIIgor Israel
- Chris FellnerCFChris Fellner
- 1 June 2015
- journal article
- Vol. 40 (6) , 372-88
Abstract
Pain modulation is a key treatment goal for diabetic peripheral neuropathy patients. Guidelines have recommended antidepressant, anticonvulsant, analgesic, and topical medications-both approved and off-label-to reduce pain in this population.Keywords
This publication has 99 references indexed in Scilit:
- Meta-analysis of duloxetine vs. pregabalin and gabapentin in the treatment of diabetic peripheral neuropathic painBMC Neurology, 2009
- Pregabalin in the Treatment of Refractory Neuropathic Pain: Results of a 15-Month Open-Label TrialPain Medicine, 2008
- Duloxetine for painful diabetic neuropathy and fibromyalgia pain: systematic review of randomised trialsBMC Neurology, 2008
- Efficacy, Safety, and Tolerability of Pregabalin Treatment for Painful Diabetic Peripheral NeuropathyDiabetes Care, 2008
- The Spectrum of Diabetic NeuropathiesPhysical Medicine and Rehabilitation Clinics of North America, 2008
- An Update on the Pharmacological Management of Post-Herpetic Neuralgia and Painful Diabetic NeuropathyCNS Drugs, 2008
- Diabetic Painful NeuropathyDrugs, 2007
- Gabapentin vs. Amitriptyline in Painful Diabetic NeuropathyJournal of Pain and Symptom Management, 2000
- Double-blind, placebo-controlled study of the application of capsaicin cream in chronic distal painful polyneuropathyPain, 1995
- Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol ): Double blind crossover trialDiabetologia, 1969